Predicting Drug Performance Through Human Biology Simulation | Tyrone Lam, CBO at GATC Health

In this episode of the Bioneex Podcast, we sit down with Tyrone Lam, Chief Business Officer at GATC Health, to explore how artificial intelligence and predictive biology are changing the way drug candidates are evaluated, developed, and de-risked. We take a closer look at GATC Health’s Operon® platform, which combines AI and systems biology modeling to simulate complex human biology and predict how drug candidates may perform before entering clinical trials. We also discuss Derisq™, GATC Health’s Operon-powered predictive risk intelligence report designed to assess areas such as efficacy, safety, off-target effects, and overall development risk. The conversation also explores the partnership between GATC Health and Bioneex and how combining Bioneex’s Search & Evaluation capabilities with GATC Health’s predictive assessment technology can create a more integrated approach to identifying, evaluating, and de-risking therapeutic opportunities.